Switzerland Approves First Next-Generation Bivalent COVID-19 Booster Vaccine
Switzerland’s regulatory authority has granted conditional approval for Moderna Inc’s (NASDAQ:MRNA) omicron-targeting bivalent booster vaccine for adults 18 years and older. Spikevax…